美国孕产妇免疫接种:全国性回顾性队列研究
本研究基于2009-2017年两个大型行政索赔数据库,评估美国孕妇破伤风-白喉-无细胞百日咳(Tdap)和流感疫苗的接种覆盖率。结果显示2010至2017年两种疫苗覆盖率均显著上升,但总体仍不理想,可能使新生儿面临百日咳和流感风险。
要点
- 2010至2017年Tdap覆盖率从1.0%升至56.3%(商业保险)、0.5%升至31.4%(医疗补助)。
- 流感疫苗覆盖率从14.7%升至31.3%(商业保险)、9.7%升至17.5%(医疗补助)。
- 年轻、黑人、农村居住、多胎妊娠及孕前住院者接种可能性较低。
核心结论
- 尽管2010至2017年美国孕产妇Tdap和流感疫苗接种覆盖率大幅上升,但仍未达理想水平,可能使新生儿面临百日咳和流感风险。
研究设计与样本
- 回顾性队列研究,数据来自MarketScan商业保险和Multi-State Medicaid行政索赔数据库,覆盖2009-2017年,2018年分析。
- 纳入分娩时年龄15-44岁的孕妇;Tdap接种终点排除孕周小于23周的妊娠。
- Tdap分析子人群包括1,421,452例商业保险和523,635例Medicaid妊娠;流感分析子人群包括1,862,705例商业保险和628,079例Medicaid妊娠。
主要发现
- 2010至2017年Tdap覆盖率从1.0%升至56.3%(商业保险),从0.5%升至31.4%(Medicaid)。
- 2010至2017年流感疫苗覆盖率从14.7%升至31.3%(商业保险),从9.7%升至17.5%(Medicaid)。
- 接种另一种疫苗以及更多妊娠相关就诊次数与Tdap/流感疫苗接种可能性显著增加相关。
临床怎么用
- 应针对接种可能性较低的孕妇(年轻、黑人、农村居住、多胎妊娠、孕前住院)制定策略以提高孕产妇疫苗接种覆盖率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: At present, pregnant women in the U.S. are recommended to receive tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) and influenza vaccines. This study assessed maternal coverage of these 2 vaccinations. METHODS: Data for this retrospective cohort study were extracted from 2 large administrative claims databases, the MarketScan Commercial and Multi-State Medicaid Databases, for 2009-2017 and analyzed in 2018. Women aged 15-44 years on the date of pregnancy end were included. Pregnancies with gestational age of less than 23 weeks were excluded from the Tdap vaccination endpoint owing to the optimal recommended gestational age for Tdap vaccination. Multivariable logistic regression models identified predictors of vaccination. RESULTS: The Tdap vaccination subpopulation included 1,421,452 Commercial and 523,635 Medicaid pregnancies; the influenza vaccination subpopulation included 1,862,705 Commercial and 628,079 Medicaid pregnancies. There were marked increases in vaccination coverage from 2010 to 2017: from 1.0% to 56.3% (Commercial) and from 0.5% to 31.4% (Medicaid) for Tdap, and from 14.7% to 31.3% (Commercial) and from 9.7% to 17.5% (Medicaid) for influenza. The likelihood of Tdap/influenza vaccination increased significantly with receipt of the other vaccine and more pregnancy-related healthcare visits. CONCLUSIONS: Although maternal Tdap and influenza vaccination coverage increased substantially from 2010 to 2017 among large, geographically diverse U.S. cohorts, coverage remained suboptimal, potentially putting newborns at risk of pertussis and influenza. Strategies to increase maternal vaccination coverage could target women identified to have a reduced likelihood of vaccination: those who are younger, black, residing in rural areas, with multiple gestation, and a prepregnancy inpatient admission.
引用
- Ghaswalla P, Poirrier JE, Packnett ER, et al. Maternal Immunization in the U.S.: A Nationwide Retrospective Cohort Study. Am J Prev Med. 2019. PMID: 31427034. doi:10.1016/j.amepre.2019.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。